Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Atypical Presentations in an Rtd Patient and Report of Novel Slc52a3 and Slc52a2 Mutations Publisher Pubmed



Sabeghi D1 ; Inanloorahatloo K1 ; Mirzadeh HS2, 3 ; Khani M1, 4 ; Shamshiri H4, 5 ; Taghavi T1 ; Alavi A4, 6 ; Boostani R7 ; Tonekaboni SH8 ; Akhondian J2 ; Ebrahimi M8 ; Salehi N9 ; Nafissi S4, 5 ; Elahi E1, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Biology, College of Science, University of Tehran, Enghelab Ave, Tehran, Iran
  2. 2. Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  3. 3. Shahid Fahmideh Children Hospital, Iran University of Medical Science, Tehran, Iran
  4. 4. Iranian Neuromusclar Research Center, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
  7. 7. Department of Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  8. 8. Pediatric Neurology, School of Medicine, Mofid Children’s Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran
  9. 9. School of Biological Science, Institute for Research in Fundamental Sciences (IPM), Tehran, Iran

Source: Acta Neurologica Belgica Published:2024


Abstract

Introduction: Riboflavin Transporter Deficiency (RTD) is a rare neurological disorder characterized by pontobulbar palsy, hearing loss, and motor cranial nerve involvement. SLC52A3 and SLC52A2 mutations are causes of RTD. SLC52A2 mutations are usually found in childhood onset cases. Fifteen Iranian RTD diagnosed patients without SLC52A2 mutations have been previously described. We aimed to identify causative mutations in two childhood cases. Methods: We recruited patients with diagnosis of BVVL. Comprehensive clinical evaluations were performed on the patients. SLC52A3 and SLC52A2 genes were PCR-amplified and Sanger sequenced. Candidate disease causing variations were screened for segregation with disease status in the respective families and control individuals. Results: A novel homozygous SLC52A3 mutation (p.Met1Val) and a heterozygous SLC52A2 mutation (p.Ala288Val) were both observed in one proband with typical RTD presentations. The aggregate of presentations in the early stages of disease in the second patient that included weakness in the lower extremities, absence of bulbar or hearing defects, prominent sensory polyneuropathy as evidenced in electrodiagnostic studies, and absence of sensory symptoms including sensory ataxia did not prompt immediate RTD diagnosis. Dysarthria and decreased hearing manifested later in the disease course. A novel homozygous SLC52A2 (p.Val314Met) mutation was identified. Conclusion: A literature search found recent reports of other atypical RTD presentations. These include MRI findings, speech understanding difficulties accompanied by normal hearing, anemia, and left ventricular non-compaction. Knowledge of unusual presentations lessens the chance of misdiagnosis or delayed RTD diagnosis which, in light of favorable effects of riboflavin supplementation, is of immense importance. © The Author(s) under exclusive licence to Belgian Neurological Society 2024.